NCT01893294View on ClinicalTrials.gov

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 30, 2015

Study Completion Date

October 30, 2015

Conditions
Duct Cell Adenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer
Interventions
DRUG

gemcitabine hydrochloride

Given IT

DRUG

fluorouracil

Given IV

RADIATION

radiation therapy

Undergo radiation therapy

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER